Passiflora Incarnata'nın Antikanser ve Antimikrobiyal Özellikleri

The original article was published on April 29, 2026. https://dergipark.org.tr/en/pub/aemj/article/1673098

Abstract

Amaç: Passiflora incarnata, flavonoid ve fenolik içeriğine bağlı olarak terapötik özellikleriyle bilinen önemli bir tıbbi bitkidir. Bu çalışmanın amacı, P. incarnata'nın sitotoksik, oksidatif stres indükleyici, apoptotik ve antimikrobiyal etkilerini araştırmaktır. Araçlar ve Yöntem: Sitotoksisite, SNU-1 mide kanseri hücrelerinde XTT testi ile değerlendirilmiş ve IC₅₀ değeri 88.95 µg/mL olarak belirlenmiştir. Oksidatif stres belirteçleri, Total Antioksidan Kapasitesi (TAC) ve Total Oksidan Seviyesi (TOS) kitleri ile ölçülmüştür. Apoptotik aktivite, BAD ve Kaspaz-3 ELISA kitleri kullanılarak analiz edilmiştir. Antimikrobiyal etkiler, üç Gramnegatif bakteri (Escherichia coli ATCC 25922, Klebsiella pneumoniae ATCC 700603 ve Pseudomonas aeruginosa ATCC 27853), iki Gram-pozitif bakteri (Staphylococcus aureus ATCC 29213 ve Enterococcus faecalis ATCC 29212) ve bir maya (Candida albicans ATCC 10231) olmak üzere altı mikroorganizma üzerinde agar disk difüzyon yöntemi ile test edilmiştir. İstatistiksel anlamlılık p<0.05 olarak kabul edilmiştir. Bulgular: P. incarnata, TAC seviyelerini anlamlı şekilde düşürmüş (p < 0.01) ve TOS seviyelerini artırmıştır (p < 0.01), bu da oksidatif stres geliştiğini göstermektedir. Ayrıca BAD ve Kaspaz-3 düzeylerini artırarak (p < 0.01) apoptozun uyarıldığını göstermiştir. İnhibisyon zonları şu şekilde ölçülmüştür: E. coli 12.27 mm, S. aureus 14.37 mm, K. pneumoniae 11.96 mm, P. aeruginosa 9.9 mm, E. faecalis 12.5 mm ve C. albicans 15.6 mm. Sonuç: P. incarnata, mide kanseri hücrelerinde oksidatif stres yoluyla apoptozu teşvik etmekte ve özellikle antifungal olmak üzere belirgin bir antimikrobiyal aktivite sergilemektedir. Bu özellikleri, antimikrobiyal dirence karşı daha fazla araştırmayı gerekli kılmaktadır.

Keywords

• Passiflora incarnata
• sitotoksisite
• oksidatif hasar
• apoptozis
• antimikrobiyal aktivite

Ethical Statement

Bu çalışma herhangi bir insan katılımcı, hayvan denek veya yazarlar tarafından gerçekleştirilen deneysel prosedürler içermediğinden, çalışma için etik kurul onayı gerekmemiştir.

Thanks

Yazarlar, bu çalışma için gerekli olanakları sağlayan Sivas Cumhuriyet Üniversitesi Tıp Fakültesi Araştırma Merkezi'ne (CÜTFAM) teşekkür ederler.

Anticancer and Antimicrobial Properties of Passiflora Incarnata

The original article was published on April 29, 2026. https://dergipark.org.tr/en/pub/aemj/article/1673098

Erratum Note

In the original published version of this paper, Figure 5 depicting the antimicrobial inhibition zones was inadvertently omitted owing to a technical issue during the typesetting and production process. The missing figure along with its caption is now included. This correction does not affect the scientific methodology, results, or conclusions of the study.

Abstract

Purpose: Passiflora incarnata is a notable medicinal plant recognized for its therapeutic properties, largely attributed to its flavonoid and phenolic content. This study aimed to investigate the cytotoxic, oxidative stress-inducing, apoptotic, and antimicrobial effects of P. incarnata. Materials and Methods: Cytotoxicity was assessed using the XTT assay in SNU-1 gastric cancer cells, determining the IC₅₀ value as 88.95 μg/mL. Oxidative stress markers were evaluated via Total Antioxidant Capacity (TAC) and Total Oxidative Status (TOS) kits. Apoptotic activity was analyzed using BAD and Caspase-3 ELISA kits. Antimicrobial effects were tested against six microorganisms—three Gram-negative bacteria (Escherichia coli ATCC 25922, Klebsiella pneumoniae ATCC 700603, and Pseudomonas aeruginosa ATCC 278538539), two Gram-positive bacteria (Staphylococcus aureus ATCC 29213 and Enterococcus faecalis ATCC 29212), and one yeast (Candida albicans ATCC 10231)—via the agar disk diffusion method. Statistical significance was defined as p<0.05. Results: P. incarnata significantly decreased TAS TAC levels (p < 0.01) and increased TOS levels (p < 0.01), indicating oxidative stress. It also elevated BAD and Caspase-3 levels (p < 0.01), suggesting apoptosis induction. Inhibition zones were E. coli 12.27 mm, S. aureus 14.37 mm, K. pneumoniae 11.96 mm, P. aeruginosa 9.9 mm, E. faecalis 12.5 mm, and C. albicans 15.6 mm Conclusion: P. incarnata promotes apoptosis through oxidative stress in gastric cancer cells and exhibits notable antimicrobial activity, particularly antifungal, warranting further investigation in combating antimicrobial resistance.

Keywords

• Passiflora incarnata
• cytotoxicity
• oxidative damage
• apoptosis
• antimicrobial activity.

Ethical Statement

This article does not contain any studies with human participants or animals performed by any of the authors. Therefore, approval from the ethics committee is not required for this study.

Thanks

The authors would like to thank the Sivas Cumhuriyet University Medical Faculty Research Centre (CÜTFAM) for providing the essential facilities for this study.

References

1. 1. World Health Organization. WHO Global Report on Traditional and Complementary Medicine 2019. Geneva: World Health Organiza-tion; 2019. https://www.who.int/publications/i/item/9789241515368 Access date 10 January, 2026.
2. 2. Vaou N, Stavropoulou E, Voidarou C, et al. Interactions between medical plant-derived bioactive compounds: focus on antimicrobial combination effects. Antibiotics. 2022;11(8):1014. doi:10.3390/antibiotics1108101
3. 3. Cowan MM. Plant products as antimicrobial agents. Clin Microbiol Rev. 1999;12(4):564-582. doi:10.1128/CMR.12.4.564
4. 4. Miroddi M, Calapai G, Navarra M, Minciullo PL, Gangemi S. Passiflora incarnata L.: ethnopharmacology, clinical application, safety and evaluation of clinical trials. J Ethnopharmacol. 2013;150(3):791-804. doi:10.1016/j.jep.2013.09.047
5. 5. Deepika B, Pallavi P, Gowtham P, Girigoswami A, Girigoswami K. Anticancer potential of nanoformulated extract of Passiflora incarnata leaves. Biocatal Agric Biotechnol. 2024;57:103109. doi:10.1016/j.bcab.2024.103109
6. 6. Viera W, Shinohara T, Samaniego I, et al. Phytochemical composition and antioxidant activity of Passiflora spp. germplasm grown in Ecuador. Plants. 2022;11(3):328. doi:10.3390/plants11030328
7. 7. Patil AS, Patil AS. Exploring Passiflora incarnata (L.): a medicinal plant’s secondary metabolites as antibacterial agent. J Med Plants Res. 2010;4(14):1496-1501. doi:10.5897/JMPR10.061
8. 8. Ramaiya SD, Bujang JS, Zakaria MH. Assessment of total phenolic, antioxidant, and antibacterial activities of Passiflora species. Sci World J. 2014;2014:167309. doi:10.1155/2014/167309

9. 9. Dhawan K, Dhawan S, Sharma A. Passiflora: a review update. J Ethnopharmacol. 2004;94(1):1-23. doi:10.1016/j.jep.2004.02.023
10. 10. Yu X, Zhang Y, Luo F, Zhou Q, Zhu L. The role of microRNAs in the gastric cancer tumor microenvironment. Mol Cancer. 2024;23(1):170. doi:10.1186/s12943-024-02084-x
11. 11. Ferlay J, Colombet M, Soerjomataram I, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144(8):1941-1953. doi:10.1002/ijc.31937
12. 12. Joha Z, Öztürk A, Yulak F, Karataş Ö, Ataseven H. Mechanism of anticancer effect of gambogic acid on gastric signet ring cell carcinoma. Med Oncol. 2023;40(9):149. doi:10.1007/s12032-023-02149-9
13. 13. Salam MA, Al-Amin MY, Salam MT, et al. Antimicrobial resistance: a growing serious threat for global public health. Healthcare. 2023;11(13):1946. doi:10.3390/healthcare11131946
14. 14. Aslam B, Wang W, Arshad MI, et al. Antibiotic resistance: a rundown of a global crisis. Infect Drug Resist. 2018;11:1645-1658. doi:10.2147/IDR.S173867
15. 15. Ricardo GA, Silvana VFG, Maria C dos SL, et al. Cytotoxic potential of 14 Passiflora species against cancer cells. J Med Plants Res. 2019;13(7):157-166. doi:10.5897/JMPR2019.6744
16. 16. Amaral RG, Gomes SVF, Andrade LN, et al. Cytotoxic, antitumor and toxicological profile of Passiflora alata leaf extract. Molecules. 2020;25(20):4814. doi:10.3390/molecules25204814
17. 17. Şahin B, Karabulut S. Sugammadex causes C6 glial cell death and exacerbates hydrogen peroxide-induced oxidative stress. Cumhuriyet Med J. 2022;44(1):1-6. doi:10.7197/cmj.1069629
18. 18. Ozturk A, Ozdemir E, Ozkaraca M, Taskiran AS, Altun A. TRPV1 channel antagonist capsazepine alleviates morphine tolerance and morphine-induced neurotoxicity by preventing mitochondrial damage and apoptosis: an in vivo and in vitro study. Naunyn Schmiedebergs Arch Pharmacol. 2025;398(6):1-12. doi:10.1007/s00210-025-04384-5
19. 19. Ozturk A, Joha Z, Basgoz N, Taskiran AS. Investigating the antiproliferative mechanisms of NaHS, a hydrogen sulfide donor, in the SHSY5Y cell line. Med Oncol. 2025;42(7):225. doi:10.1007/s12032-025-02772-8
20. 20. Tastemur S, Kaleci AO, Ozturk A, Mendil AS. Astaxanthin promotes apoptosis by suppressing growth signaling pathways in HT-29 colorectal cancer cells. Med Oncol. 2025;42(9):426. doi:10.1007/s12032-025-02978-w
21. 21. Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem.2004;37(2):112-119. doi:10.1016/j.clinbiochem.2003.10.014
22. 22. Ozturk A, Taskiran AS, Gundogdu E. The role of oxidative stress in the protective effect of boric acid against glutamate excitotoxicity in C6 glioma cells. J Boron. 2025;10(1):1-9. doi:10.30728/boron.1519354
23. 23. Alandag C, Ozturk A, Yulak F, et al. HER-2 SMASH. Cancer Chemother Pharmacol. 2025;95(1):10. doi:10.1007/s00280-024-04726-9
24. 24. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Disk Susceptibility Tests: Approved Standard. 12th ed. CLSI; 2015. Available from: https://clsi.org/standards/products/microbiology/documents/m02/
25. 25. Rios JL, Recio MC, Villar A. Screening methods for natural products with antimicrobial activity: a review of the literature. J Ethnopharmacol. 1988;23(2-3):127-149. doi:10.1016/0378-8741(88)90001-3
26. 26. Bauer AW, Kirby WM, Sherris JC, Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol.1966;45(4):493-496. Available from: https://pubmed.ncbi.nlm.nih.gov/5325707/
27. 27. Simiao MJ, Barboza JS, Vianna MG, et al. A comparative study of phytoconstituents and antibacterial activity of in vitro derived materials of four Passiflora species. An Acad Bras Cienc. 2018;90(3):2805-2813. doi:10.1590/0001-3765201820170809
28. 28. Bhargav HS, Shastri SD, Poornav SP, Darshan KM, Nayak MM. Measurement of the zone of inhibition of an antibiotic. In: 2016 IEEE 6th International Conference on Advanced Computing (IACC). IEEE; 2016:409-414. doi:10.1109/IACC.2016.82
29. 29. Ozarowski M, Piasecka A, Paszel-Jaworska A, et al. Comparison of bioactive compound content in leaf extracts of Passiflora incarnata, P. caerulea and P. alata and in vitro cytotoxic potential on leukemia cell lines. Rev Bras Farmacogn. 2018;28(2):179-191. doi:10.1016/j.bjp.2018.01.006
30. 30. Amaral RG, Gomes SVF, Andrade LN, et al. Cytotoxic, antitumor and toxicological profile of Passiflora alata leaf extract. Molecules. 2020;25(20):4814. doi:10.3390/molecules25204814
31. 31. Dhawan K, Kumar S, Sharma A. Anxiolytic activity of aerial and underground parts of Passiflora incarnata. Fitoterapia. 2001;72(8):922-926. doi:10.1016/S0367-326X(01)00322-7
32. 32. Kalwij JM. Review of ‘The Plant List, a working list of all plant species. J Veg Sci. 2012;23(5):998-1002. doi:10.1111/j.1654-1103.2012.01407.x
33. 33. Alam Ripa F, Nahar L, Haque M, Monirul Islam M. Antibacterial, cytotoxic and antioxidant activity of Passiflora edulis Sims. Eur J Sci Res. 2009;31:1-10. doi:10.5251/ABJNA.2011.2.4.713.719
34. 34. Rizwana H, Al Otibi F, Al-Malki N. Chemical composition, FTIR studies and antibacterial activity of Passiflora edulis f. edulis (fruit). J Pure Appl Microbiol. 2019;13(4):2489-2498. doi:10.22207/JPAM.13.4.64
35. 35. Madhumathi S, Rajendran A. Antimicrobial activity of leaf extract of Passiflora incarnata L. Int J Appl Biol Pharm Technol. 2011;2(2):481-486. https://cdn.fortunejournals.com/articles/ijabpt/pdf/77071-S